• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[10种新型4-喹诺酮类药物对肠道致病菌的体外活性比较]

[Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].

作者信息

Habiyaremye I, Verbist L, Vandepitte J

机构信息

Laboratoire de Bactériologie, Clinique Universitaire St Raphaël, Leuven, Belgique.

出版信息

Pathol Biol (Paris). 1987 Jun;35(5 Pt 2):800-4.

PMID:3116489
Abstract

The susceptibility has been determined of 169 Shigella spp., 93 Salmonella spp., 68 Yersinia enterocolitica, 34 Vibrio cholerae 0:1, and 34 Campylobacter jejuni, isolated in Central Africa and in Belgium, to ten fluoroquinolones: ciprofloxacin, ofloxacin, norfloxacin, pefloxacin, enoxacin, amifloxacin, CI-934, A-56619, A-56620 and RO 23-6240. All quinolones were active against the strains tested, showing an MIC90 between 0.004 mg/l and 2 mg/l for strains susceptible to nalidixic acid and an MIC90 between 0.12 and 4 mg/l for resistant strains. Ciprofloxacin was the most active compound against Shigella spp., Salmonella spp. and Y. enterocolitica. A-56620 was the most active against C. jejuni; and both compounds were equal in activity against V. cholerae. The MBCs of all ten compounds were either similar to the MIC or one concentration higher. Killing curves show that the quinolones are bactericidal for the strains tested within 2 to 8 h of contact with concentrations corresponding to 2 or 8 times the MIC.

摘要

已测定从中非和比利时分离出的169株志贺氏菌属、93株沙门氏菌属、68株小肠结肠炎耶尔森氏菌、34株霍乱弧菌0:1和34株空肠弯曲菌对十种氟喹诺酮类药物的敏感性:环丙沙星、氧氟沙星、诺氟沙星、培氟沙星、依诺沙星、阿米氟沙星、CI-934、A-56619、A-56620和RO 23-6240。所有喹诺酮类药物对测试菌株均有活性,对萘啶酸敏感的菌株MIC90在0.004 mg/l至2 mg/l之间,耐药菌株的MIC90在0.12至4 mg/l之间。环丙沙星是对志贺氏菌属、沙门氏菌属和小肠结肠炎耶尔森氏菌最具活性的化合物。A-56620对空肠弯曲菌最具活性;这两种化合物对霍乱弧菌的活性相当。所有十种化合物的MBC与MIC相似或高一个浓度。杀菌曲线表明,喹诺酮类药物在与相当于MIC的2倍或8倍浓度接触2至8小时内对测试菌株具有杀菌作用。

相似文献

1
[Comparative in vitro activity of 10 new 4-quinolones against enteropathogenic bacteria].[10种新型4-喹诺酮类药物对肠道致病菌的体外活性比较]
Pathol Biol (Paris). 1987 Jun;35(5 Pt 2):800-4.
2
The comparative in vitro activity of twelve 4-quinolone antimicrobials against enteric pathogens.十二种4-喹诺酮类抗菌药物对肠道病原体的体外活性比较
Drugs Exp Clin Res. 1985;11(4):253-7.
3
The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.
Infection. 1986 Nov-Dec;14(6):294-8. doi: 10.1007/BF01643966.
4
[Compared antibacterial activity of a new fluoroquinolone, sparfloxacin (AT 4140, RP 64206) and four other fluoroquinolones against 332 strains of enteropathogen bacteria].[新型氟喹诺酮类药物司帕沙星(AT 4140,RP 64206)与其他四种氟喹诺酮类药物对332株肠道病原菌的抗菌活性比较]
Pathol Biol (Paris). 1993 Apr;41(4):294-301.
5
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.八种新型喹诺酮类药物与萘啶酸的体外活性比较
J Antimicrob Chemother. 1986 Nov;18 Suppl D:1-20. doi: 10.1093/jac/18.supplement_d.1.
6
[In vitro activity of new quinolones against Mycoplasma pathogenic to humans].新型喹诺酮类药物对人致病性支原体的体外活性
Pathol Biol (Paris). 1988 May;36(5):496-9.
7
In-vitro activity of newer quinolones against aerobic bacteria.新型喹诺酮类药物对需氧菌的体外活性
J Antimicrob Chemother. 1986 Apr;17 Suppl B:29-39. doi: 10.1093/jac/17.suppl_b.29.
8
[In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].[两种新型喹诺酮类药物的体外抗菌活性:A 56619(双氟沙星)和A 56620。与培氟沙星、氧氟沙星和环丙沙星的比较]
Pathol Biol (Paris). 1987 Jun;35(5 Pt 2):759-67.
9
Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.依诺沙星、环丙沙星、阿米氟沙星、诺氟沙星和氧氟沙星对177株细菌分离株的抗菌活性比较
J Antimicrob Chemother. 1986 May;17(5):623-8. doi: 10.1093/jac/17.5.623.
10
Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.培氟沙星、氧氟沙星、依诺沙星和环丙沙星对256株临床分离株的体外活性比较
Acta Pathol Microbiol Immunol Scand B. 1987 Apr;95(2):141-6. doi: 10.1111/j.1699-0463.1987.tb03102.x.

引用本文的文献

1
Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.氟罗沙星。对其在各种感染中的药理学及治疗效果的综述。
Drugs. 1995 May;49(5):794-850. doi: 10.2165/00003495-199549050-00010.
2
Monitoring of antibiotic resistance in shigellae isolated in The Netherlands 1984-1989.1984 - 1989年荷兰分离的志贺氏菌抗生素耐药性监测
Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):164-7. doi: 10.1007/BF01967070.